X-linked inhibitor of apoptosis protein (XIAP) is a nonredundant modulator of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis in human cancer cells - PubMed (original) (raw)
X-linked inhibitor of apoptosis protein (XIAP) is a nonredundant modulator of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis in human cancer cells
Jordan M Cummins et al. Cancer Res. 2004.
Abstract
Although the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) has been shown to play an important role in the immunosurveillance of neoplasia, apoptotic factors that modulate the sensitivity of cancer cells to TRAIL are poorly understood. The inhibitor of apoptosis proteins (IAPs) have generated considerable interest as potential targets for cancer therapy, but the lack of a phenotype in X-linked IAP (XIAP) knockout mice has generated speculation that IAP function may be redundant. Using gene targeting technology, we show that disruption of the gene encoding XIAP in human cancer cells did not interfere with basal proliferation, but caused a remarkable sensitivity to TRAIL. These results demonstrate that XIAP is a nonredundant modulator of TRAIL-mediated apoptosis and provide a rationale for XIAP as a therapeutic target.
Similar articles
- Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy.
Almasan A, Ashkenazi A. Almasan A, et al. Cytokine Growth Factor Rev. 2003 Jun-Aug;14(3-4):337-48. doi: 10.1016/s1359-6101(03)00029-7. Cytokine Growth Factor Rev. 2003. PMID: 12787570 Review. - Regulation of TRAIL-induced apoptosis by ectopic expression of antiapoptotic factors.
Aggarwal BB, Bhardwaj U, Takada Y. Aggarwal BB, et al. Vitam Horm. 2004;67:453-83. doi: 10.1016/S0083-6729(04)67023-3. Vitam Horm. 2004. PMID: 15110190 Review.
Cited by
- Recent advances in targeting the "undruggable" proteins: from drug discovery to clinical trials.
Xie X, Yu T, Li X, Zhang N, Foster LJ, Peng C, Huang W, He G. Xie X, et al. Signal Transduct Target Ther. 2023 Sep 6;8(1):335. doi: 10.1038/s41392-023-01589-z. Signal Transduct Target Ther. 2023. PMID: 37669923 Free PMC article. Review. - Escaping cell death via TRAIL decoy receptors: a systematic review of their roles and expressions in colorectal cancer.
Jong KXJ, Mohamed EHM, Ibrahim ZA. Jong KXJ, et al. Apoptosis. 2022 Dec;27(11-12):787-799. doi: 10.1007/s10495-022-01774-5. Epub 2022 Oct 7. Apoptosis. 2022. PMID: 36207556 Review. - XIAP promotes melanoma growth by inducing tumour neutrophil infiltration.
Daoud M, Broxtermann PN, Schorn F, Werthenbach JP, Seeger JM, Schiffmann LM, Brinkmann K, Vucic D, Tüting T, Mauch C, Kulms D, Zigrino P, Kashkar H. Daoud M, et al. EMBO Rep. 2022 Jun 7;23(6):e53608. doi: 10.15252/embr.202153608. Epub 2022 Apr 19. EMBO Rep. 2022. PMID: 35437868 Free PMC article. - Regulation of CYLD activity and specificity by phosphorylation and ubiquitin-binding CAP-Gly domains.
Elliott PR, Leske D, Wagstaff J, Schlicher L, Berridge G, Maslen S, Timmermann F, Ma B, Fischer R, Freund SMV, Komander D, Gyrd-Hansen M. Elliott PR, et al. Cell Rep. 2021 Oct 5;37(1):109777. doi: 10.1016/j.celrep.2021.109777. Cell Rep. 2021. PMID: 34610306 Free PMC article. - Mutual regulation between OGT and XIAP to control colon cancer cell growth and invasion.
Seo HG, Kim HB, Yoon JY, Kweon TH, Park YS, Kang J, Jung J, Son S, Yi EC, Lee TH, Yang WH, Cho JW. Seo HG, et al. Cell Death Dis. 2020 Sep 29;11(9):815. doi: 10.1038/s41419-020-02999-5. Cell Death Dis. 2020. PMID: 32994395 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials